ID   PTC1_HUMAN              Reviewed;        1447 AA.
AC   Q13635; A3KBI9; E9PEJ8; Q13463; Q5R1U7; Q5R1U9; Q5R1V0; Q5VZC0;
AC   Q5VZC2; Q86XG7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   21-MAR-2012, entry version 123.
DE   RecName: Full=Protein patched homolog 1;
DE            Short=PTC;
DE            Short=PTC1;
GN   Name=PTCH1; Synonyms=PTCH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM L), AND VARIANTS BCC PRO-175;
RP   PRO-ASN-ILE-815 INS AND LEU-1315.
RC   TISSUE=Lung;
RX   MEDLINE=96247324; PubMed=8658145; DOI=10.1126/science.272.5268.1668;
RA   Johnson R.L., Rothman A.L., Xie J., Goodrich L.V., Bare J.W.,
RA   Bonifas J.M., Quinn A.G., Myers R.M., Cox D.R., Epstein E.H. Jr.,
RA   Scott M.P.;
RT   "Human homolog of patched, a candidate gene for the basal cell nevus
RT   syndrome.";
RL   Science 272:1668-1671(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM S), AND VARIANT LEU-1315.
RC   TISSUE=Fetal brain;
RX   MEDLINE=96218118; PubMed=8647801; DOI=10.1074/jbc.271.21.12125;
RA   Hahn H., Christiansen J., Wicking C., Zaphiropolous P.G.,
RA   Chidambaram A., Gerrard B., Vorechovsky I., Bale A.E., Toftgard R.,
RA   Dean M., Wainwright B.J.;
RT   "A mammalian patched homolog is expressed in target tissues of sonic
RT   hedgehog and maps to a region associated with developmental
RT   abnormalities.";
RL   J. Biol. Chem. 271:12125-12128(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-324 (ISOFORM L'), NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 1-259 (ISOFORM M), NUCLEOTIDE SEQUENCE [MRNA] OF 1-174
RP   (ISOFORM S), AND ALTERNATIVE SPLICING.
RX   PubMed=15780749; DOI=10.1016/j.ygeno.2004.11.014;
RA   Nagao K., Toyoda M., Takeuchi-Inoue K., Fujii K., Yamada M.,
RA   Miyashita T.;
RT   "Identification and characterization of multiple isoforms of a murine
RT   and human tumor suppressor, patched, having distinct first exons.";
RL   Genomics 85:462-471(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-183 (ISOFORM M).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-90 (ISOFORM S), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=17310997; DOI=10.1038/sj.onc.1210301;
RA   Shimokawa T., Svard J., Heby-Henricson K., Teglund S., Toftgard R.,
RA   Zaphiropoulos P.G.;
RT   "Distinct roles of first exon variants of the tumor-suppressor
RT   Patched1 in Hedgehog signaling.";
RL   Oncogene 26:4889-4896(2007).
RN   [7]
RP   INTERACTION WITH SNX17.
RX   PubMed=15769472; DOI=10.1016/j.jmb.2005.02.004;
RA   Knauth P., Schlueter T., Czubayko M., Kirsch C., Florian V.,
RA   Schreckenberger S., Hahn H., Bohnensack R.;
RT   "Functions of sorting nexin 17 domains and recognition motif for P-
RT   selectin trafficking.";
RL   J. Mol. Biol. 347:813-825(2005).
RN   [8]
RP   VARIANTS BCNS ARG-509; VAL-509; GLN-816 DEL AND TYR-1132.
RX   MEDLINE=96438609; PubMed=8840969;
RA   Chidambaram A., Goldstein A.M., Gailani M.R., Gerrard B., Bale S.J.,
RA   DiGiovanna J.J., Bale A.E., Dean M.;
RT   "Mutations in the human homologue of the Drosophila patched gene in
RT   Caucasian and African-American nevoid basal cell carcinoma syndrome
RT   patients.";
RL   Cancer Res. 56:4599-4601(1996).
RN   [9]
RP   VARIANTS BCNS TYR-513 AND ARG-1069.
RX   MEDLINE=97136566; PubMed=8981943;
RA   Wicking C., Shanley S., Smyth I., Gillies S., Negus K., Graham S.,
RA   Suthers G., Haites N., Edwards M., Wainwright B.J.,
RA   Chenevix-Trench G.;
RT   "Most germ-line mutations in the nevoid basal cell carcinoma syndrome
RT   lead to a premature termination of the PATCHED protein, and no
RT   genotype-phenotype correlations are evident.";
RL   Am. J. Hum. Genet. 60:21-26(1997).
RN   [10]
RP   VARIANT NBCCS ASP-1438.
RX   MEDLINE=98001068; PubMed=9341860; DOI=10.1007/s004390050541;
RA   Lench N.J., Telford E.A.R., High A.S., Markham A.F., Wicking C.,
RA   Wainwright B.J.;
RT   "Characterisation of human patched germ line mutations in naevoid
RT   basal cell carcinoma syndrome.";
RL   Hum. Genet. 100:497-502(1997).
RN   [11]
RP   VARIANT LEU-1315.
RX   MEDLINE=99211211; PubMed=10200051;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:6<480::AID-HUMU9>3.3.CO;2-W;
RA   Hasenpusch-Theil K., Bataille V., Laehdetie J., Obermayr F.,
RA   Sampson J.R., Frischauf A.-M.;
RT   "Gorlin syndrome: identification of 4 novel germ-line mutations of the
RT   human patched (PTCH) gene.";
RL   Hum. Mutat. 11:480-480(1998).
RN   [12]
RP   VARIANTS BCNS SER-376 AND VAL-1083 INS, AND VARIANT BCC TRP-1114.
RX   MEDLINE=98281604; PubMed=9620294;
RX   DOI=10.1046/j.1523-1747.1998.00222.x;
RA   Aszterbaum M., Rothman A.L., Johnson R.L., Fisher M., Xie J.,
RA   Bonifas J.M., Zhang X., Scott M.P., Epstein E.H. Jr.;
RT   "Identification of mutations in the human PATCHED gene in sporadic
RT   basal cell carcinomas and in patients with the basal cell nevus
RT   syndrome.";
RL   J. Invest. Dermatol. 110:885-888(1998).
RN   [13]
RP   VARIANT LEU-1315.
RX   MEDLINE=20334946; PubMed=10874314;
RX   DOI=10.1002/1098-1004(200007)16:1<89::AID-HUMU18>3.3.CO;2-Z;
RA   Dong J., Gailani M.R., Pomeroy S.L., Reardon D., Bale A.E.;
RT   "Identification of PATCHED mutations in medulloblastomas by direct
RT   sequencing.";
RL   Hum. Mutat. 16:89-90(2000).
RN   [14]
RP   VARIANT BCNS PRO-1132.
RX   MEDLINE=21154106; PubMed=11231326;
RX   DOI=10.1046/j.1523-1747.2001.01279-2.x;
RA   Reifenberger J., Arnold N., Kiechle M., Reifenberger G., Hauschild A.;
RT   "Coincident PTCH and BRCA1 germline mutations in a patient with nevoid
RT   basal cell carcinoma syndrome and familial breast cancer.";
RL   J. Invest. Dermatol. 116:472-474(2001).
RN   [15]
RP   VARIANTS SQUAMOUS CELL CARCINOMA MET-829 AND LYS-1242.
RX   MEDLINE=21184537; PubMed=11286632;
RX   DOI=10.1046/j.1523-1747.2001.01301.x;
RA   Ping X.L., Ratner D., Zhang H., Wu X.L., Zhang M.J., Chen F.F.,
RA   Silvers D.N., Peacocke M., Tsou H.C.;
RT   "PTCH mutations in squamous cell carcinoma of the skin.";
RL   J. Invest. Dermatol. 116:614-616(2001).
RN   [16]
RP   VARIANTS HPE7 THR-393; MET-728; GLY-827 AND MET-1052.
RX   PubMed=11941477; DOI=10.1007/s00439-002-0695-5;
RA   Ming J.E., Kaupas M.E., Roessler E., Brunner H.G., Golabi M.,
RA   Tekin M., Stratton R.F., Sujansky E., Bale S.J., Muenke M.;
RT   "Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are
RT   associated with holoprosencephaly.";
RL   Hum. Genet. 110:297-301(2002).
RN   [17]
RP   ERRATUM.
RA   Ming J.E., Kaupas M.E., Roessler E., Brunner H.G., Golabi M.,
RA   Tekin M., Stratton R.F., Sujansky E., Bale S.J., Muenke M.;
RL   Hum. Genet. 111:464-464(2002).
RN   [18]
RP   VARIANTS BCNS PRO-230 AND 505-LEU-ARG-506.
RX   PubMed=15459969; DOI=10.1002/humu.9289;
RA   Savino M., d'Apolito M., Formica V., Baorda F., Mari F., Renieri A.,
RA   Carabba E., Tarantino E., Andreucci E., Belli S., Lo Muzio L.,
RA   Dallapiccola B., Zelante L., Savoia A.;
RT   "Spectrum of PTCH mutations in Italian nevoid basal cell-carcinoma
RT   syndrome patients: identification of thirteen novel alleles.";
RL   Hum. Mutat. 24:441-441(2004).
RN   [19]
RP   VARIANT HPE7 MET-728.
RX   PubMed=17096318; DOI=10.1002/ajmg.a.31370;
RA   Rahimov F., Ribeiro L.A., de Miranda E., Richieri-Costa A.,
RA   Murray J.C.;
RT   "GLI2 mutations in four Brazilian patients: how wide is the phenotypic
RT   spectrum?";
RL   Am. J. Med. Genet. A 140:2571-2576(2006).
RN   [20]
RP   VARIANTS HPE7 GLY-443; GLY-751; GLY-908 AND MET-1052.
RX   PubMed=17001668; DOI=10.1002/ajmg.a.31369;
RA   Ribeiro L.A., Murray J.C., Richieri-Costa A.;
RT   "PTCH mutations in four Brazilian patients with holoprosencephaly and
RT   in one with holoprosencephaly-like features and normal MRI.";
RL   Am. J. Med. Genet. A 140:2584-2586(2006).
CC   -!- FUNCTION: Acts as a receptor for sonic hedgehog (SHH), indian
CC       hedgehog (IHH) and desert hedgehog (DHH). Associates with the
CC       smoothened protein (SMO) to transduce the hedgehog's proteins
CC       signal. Seems to have a tumor suppressor function, as inactivation
CC       of this protein is probably a necessary, if not sufficient step
CC       for tumorigenesis.
CC   -!- SUBUNIT: Interacts with SNX17.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=L; Synonyms=1B;
CC         IsoId=Q13635-1; Sequence=Displayed;
CC       Name=L'; Synonyms=1Ckid;
CC         IsoId=Q13635-2; Sequence=VSP_041369;
CC       Name=M; Synonyms=1C;
CC         IsoId=Q13635-3; Sequence=VSP_041371;
CC       Name=S; Synonyms=1A, 1CdeltaE2;
CC         IsoId=Q13635-4; Sequence=VSP_041370;
CC   -!- TISSUE SPECIFICITY: In the adult, expressed in brain, lung, liver,
CC       heart, placenta, skeletal muscle, pancreas and kidney. Expressed
CC       in tumor cells but not in normal skin.
CC   -!- DEVELOPMENTAL STAGE: In the embryo, found in all major target
CC       tissues of sonic hedgehog, such as the ventral neural tube,
CC       somites, and tissues surrounding the zone of polarizing activity
CC       of the limb bud.
CC   -!- PTM: Glycosylation is necessary for SHH binding (By similarity).
CC   -!- DISEASE: Defects in PTCH1 are probably the cause of basal cell
CC       nevus syndrome (BCNS) [MIM:109400]; also known as Gorlin syndrome
CC       or Gorlin-Goltz syndrome. BCNS is an autosomal dominant disease
CC       characterized by nevoid basal cell carcinomas (NBCCS) and
CC       developmental abnormalities such as rib and craniofacial
CC       alterations, polydactyly, syndactyly, and spina bifida. In
CC       addition, the patients suffer from a multitude of tumors like
CC       basal cell carcinomas (BCC), fibromas of the ovaries and heart,
CC       cysts of the skin, jaws and mesentery, as well as medulloblastomas
CC       and meningiomas. PTCH1 is also mutated in squamous cell carcinoma
CC       (SCC). Could also be associated with large body size observed in
CC       BCNS patients.
CC   -!- DISEASE: Defects in PTCH1 are a cause of sporadic basal cell
CC       carcinoma (BCC) [MIM:605462].
CC   -!- DISEASE: Defects in PTCH1 are the cause of holoprosencephaly type
CC       7 (HPE7) [MIM:610828]. Holoprosencephaly (HPE) [MIM:236100] is the
CC       most common structural anomaly of the brain, in which the
CC       developing forebrain fails to correctly separate into right and
CC       left hemispheres. Holoprosencephaly is genetically heterogeneous
CC       and associated with several distinct facies and phenotypic
CC       variability.
CC   -!- SIMILARITY: Belongs to the patched family.
CC   -!- SIMILARITY: Contains 1 SSD (sterol-sensing) domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTCH100.html";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/PTCH1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U59464; AAC50550.1; -; mRNA.
DR   EMBL; U43148; AAC50496.1; -; mRNA.
DR   EMBL; AL161729; CAH73817.1; -; Genomic_DNA.
DR   EMBL; AL161729; CAH73818.1; -; Genomic_DNA.
DR   EMBL; AB189436; BAD74184.1; -; mRNA.
DR   EMBL; AB189437; BAD74185.1; -; mRNA.
DR   EMBL; AB189438; BAD74186.1; -; mRNA.
DR   EMBL; AB189439; BAD74187.1; -; mRNA.
DR   EMBL; AB189440; BAD74188.1; -; mRNA.
DR   EMBL; BC043542; AAH43542.1; -; mRNA.
DR   EMBL; AB239329; BAF47712.1; -; mRNA.
DR   IPI; IPI00014374; -.
DR   IPI; IPI00643862; -.
DR   IPI; IPI00654901; -.
DR   IPI; IPI00844057; -.
DR   RefSeq; NP_000255.2; NM_000264.3.
DR   RefSeq; NP_001077071.1; NM_001083602.1.
DR   RefSeq; NP_001077072.1; NM_001083603.1.
DR   RefSeq; NP_001077073.1; NM_001083604.1.
DR   RefSeq; NP_001077074.1; NM_001083605.1.
DR   RefSeq; NP_001077075.1; NM_001083606.1.
DR   RefSeq; NP_001077076.1; NM_001083607.1.
DR   UniGene; Hs.494538; -.
DR   ProteinModelPortal; Q13635; -.
DR   DIP; DIP-44940N; -.
DR   STRING; Q13635; -.
DR   PhosphoSite; Q13635; -.
DR   DMDM; 160415977; -.
DR   PRIDE; Q13635; -.
DR   DNASU; 5727; -.
DR   Ensembl; ENST00000331920; ENSP00000332353; ENSG00000185920.
DR   Ensembl; ENST00000375274; ENSP00000364423; ENSG00000185920.
DR   GeneID; 5727; -.
DR   KEGG; hsa:5727; -.
DR   UCSC; uc004avk.2; human.
DR   CTD; 5727; -.
DR   GeneCards; GC09M098205; -.
DR   H-InvDB; HIX0025725; -.
DR   HGNC; HGNC:9585; PTCH1.
DR   HPA; CAB013717; -.
DR   MIM; 109400; phenotype.
DR   MIM; 601309; gene.
DR   MIM; 605462; phenotype.
DR   MIM; 610828; phenotype.
DR   neXtProt; NX_Q13635; -.
DR   Orphanet; 377; Gorlin syndrome.
DR   Orphanet; 2162; Holoprosencephaly.
DR   PharmGKB; PA162400269; -.
DR   PharmGKB; PA33937; -.
DR   eggNOG; NOG313603; -.
DR   GeneTree; ENSGT00550000074234; -.
DR   HOGENOM; HBG713504; -.
DR   HOVERGEN; HBG003801; -.
DR   InParanoid; Q13635; -.
DR   KO; K06225; -.
DR   OMA; RPSYCDA; -.
DR   OrthoDB; EOG40S0DT; -.
DR   PhylomeDB; Q13635; -.
DR   Pathway_Interaction_DB; glypican_3pathway; Glypican 3 network.
DR   Pathway_Interaction_DB; hedgehog_glipathway; Hedgehog signaling events mediated by Gli proteins.
DR   Pathway_Interaction_DB; hedgehog_2pathway; Signaling events mediated by the Hedgehog family.
DR   Reactome; REACT_111102; Signal Transduction.
DR   NextBio; 22266; -.
DR   ArrayExpress; Q13635; -.
DR   Bgee; Q13635; -.
DR   CleanEx; HS_PTCH1; -.
DR   Genevestigator; Q13635; -.
DR   GermOnline; ENSG00000185920; Homo sapiens.
DR   GO; GO:0005901; C:caveola; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral to plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0015485; F:cholesterol binding; IDA:BHF-UCL.
DR   GO; GO:0030332; F:cyclin binding; IPI:BHF-UCL.
DR   GO; GO:0097108; F:hedgehog family protein binding; IPI:BHF-UCL.
DR   GO; GO:0008158; F:hedgehog receptor activity; IEA:InterPro.
DR   GO; GO:0005119; F:smoothened binding; IPI:BHF-UCL.
DR   GO; GO:0007420; P:brain development; ISS:BHF-UCL.
DR   GO; GO:0071397; P:cellular response to cholesterol; IMP:BHF-UCL.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; ISS:UniProtKB.
DR   GO; GO:0040015; P:negative regulation of multicellular organism growth; ISS:UniProtKB.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IMP:BHF-UCL.
DR   GO; GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL.
DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0021997; P:neural plate axis specification; ISS:BHF-UCL.
DR   GO; GO:0060037; P:pharyngeal system development; IMP:BHF-UCL.
DR   GO; GO:0010875; P:positive regulation of cholesterol efflux; IDA:BHF-UCL.
DR   GO; GO:0016485; P:protein processing; ISS:UniProtKB.
DR   GO; GO:0072661; P:protein targeting to plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0007224; P:smoothened signaling pathway; IEP:UniProtKB.
DR   GO; GO:0061053; P:somite development; IMP:BHF-UCL.
DR   InterPro; IPR003392; Patched.
DR   InterPro; IPR000731; SSD.
DR   InterPro; IPR004766; TM_rcpt_patched.
DR   Pfam; PF02460; Patched; 1.
DR   TIGRFAMs; TIGR00918; 2A060602; 1.
DR   PROSITE; PS50156; SSD; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Glycoprotein; Holoprosencephaly; Membrane; Polymorphism; Receptor;
KW   Reference proteome; Transmembrane; Transmembrane helix;
KW   Tumor suppressor.
FT   CHAIN         1   1447       Protein patched homolog 1.
FT                                /FTId=PRO_0000205964.
FT   TOPO_DOM      1    100       Cytoplasmic (Potential).
FT   TRANSMEM    101    121       Helical; (Potential).
FT   TOPO_DOM    122    436       Extracellular (Potential).
FT   TRANSMEM    437    457       Helical; (Potential).
FT   TOPO_DOM    458    472       Cytoplasmic (Potential).
FT   TRANSMEM    473    493       Helical; (Potential).
FT   TOPO_DOM    494    501       Extracellular (Potential).
FT   TRANSMEM    502    522       Helical; (Potential).
FT   TOPO_DOM    523    547       Cytoplasmic (Potential).
FT   TRANSMEM    548    568       Helical; (Potential).
FT   TOPO_DOM    569    577       Extracellular (Potential).
FT   TRANSMEM    578    598       Helical; (Potential).
FT   TOPO_DOM    599    748       Cytoplasmic (Potential).
FT   TRANSMEM    749    769       Helical; (Potential).
FT   TOPO_DOM    770   1027       Extracellular (Potential).
FT   TRANSMEM   1028   1048       Helical; (Potential).
FT   TOPO_DOM   1049   1055       Cytoplasmic (Potential).
FT   TRANSMEM   1056   1076       Helical; (Potential).
FT   TOPO_DOM   1077   1083       Extracellular (Potential).
FT   TRANSMEM   1084   1104       Helical; (Potential).
FT   TOPO_DOM   1105   1121       Cytoplasmic (Potential).
FT   TRANSMEM   1122   1141       Helical; (Potential).
FT   TOPO_DOM   1142   1154       Extracellular (Potential).
FT   TRANSMEM   1155   1175       Helical; (Potential).
FT   TOPO_DOM   1176   1447       Cytoplasmic (Potential).
FT   DOMAIN      438    598       SSD.
FT   COMPBIAS     14     31       Gly-rich.
FT   CARBOHYD    141    141       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    312    312       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    349    349       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    414    414       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    875    875       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1000   1000       N-linked (GlcNAc...) (Potential).
FT   VAR_SEQ       1     66       MASAGNAAEPQDRGGGGSGCIGAPGRPAGGGRRRRTGGLRR
FT                                AAAPDRDYLHRPSYCDAAFALEQIS -> MELLNRNRLVIV
FT                                SPRCTPPKASGGPARRGFYTFRSFCKDGGGGEEEEENGGEE
FT                                KDDRGDKETRSD (in isoform L').
FT                                /FTId=VSP_041369.
FT   VAR_SEQ       2    152       Missing (in isoform S).
FT                                /FTId=VSP_041370.
FT   VAR_SEQ       2     67       Missing (in isoform M).
FT                                /FTId=VSP_041371.
FT   VARIANT     175    175       L -> P (in BCNS; sporadic BCC).
FT                                /FTId=VAR_007843.
FT   VARIANT     230    230       T -> P (in BCNS).
FT                                /FTId=VAR_020845.
FT   VARIANT     376    376       F -> S (in BCNS).
FT                                /FTId=VAR_007844.
FT   VARIANT     393    393       A -> T (in HPE7).
FT                                /FTId=VAR_032952.
FT   VARIANT     443    443       A -> G (in HPE7).
FT                                /FTId=VAR_032953.
FT   VARIANT     505    506       FL -> LR (in BCNS).
FT                                /FTId=VAR_020846.
FT   VARIANT     509    509       G -> R (in BCNS; could be a rare
FT                                polymorphism).
FT                                /FTId=VAR_010974.
FT   VARIANT     509    509       G -> V (in BCNS).
FT                                /FTId=VAR_010975.
FT   VARIANT     513    513       D -> Y (in BCNS).
FT                                /FTId=VAR_010976.
FT   VARIANT     728    728       T -> M (in HPE7; dbSNP:rs28936404).
FT                                /FTId=VAR_032954.
FT   VARIANT     751    751       V -> G (in HPE7).
FT                                /FTId=VAR_032955.
FT   VARIANT     815    815       I -> IPNI (in BCNS).
FT                                /FTId=VAR_007845.
FT   VARIANT     816    816       Missing (in BCNS).
FT                                /FTId=VAR_010977.
FT   VARIANT     827    827       S -> G (in HPE7).
FT                                /FTId=VAR_032956.
FT   VARIANT     829    829       V -> M (in squamous cell carcinoma).
FT                                /FTId=VAR_010978.
FT   VARIANT     908    908       V -> G (in HPE7).
FT                                /FTId=VAR_032957.
FT   VARIANT    1052   1052       T -> M (in HPE7; dbSNP:rs28936405).
FT                                /FTId=VAR_032958.
FT   VARIANT    1069   1069       G -> R (in BCNS).
FT                                /FTId=VAR_010979.
FT   VARIANT    1083   1083       V -> VV (in BCNS).
FT                                /FTId=VAR_007846.
FT   VARIANT    1114   1114       R -> W (in BCNS and BCC).
FT                                /FTId=VAR_007847.
FT   VARIANT    1132   1132       S -> P (in BCNS).
FT                                /FTId=VAR_010980.
FT   VARIANT    1132   1132       S -> Y (in BCNS).
FT                                /FTId=VAR_010981.
FT   VARIANT    1195   1195       T -> S (in dbSNP:rs2236405).
FT                                /FTId=VAR_020440.
FT   VARIANT    1242   1242       E -> K (in squamous cell carcinoma).
FT                                /FTId=VAR_010982.
FT   VARIANT    1282   1282       P -> L (in dbSNP:rs2227968).
FT                                /FTId=VAR_020847.
FT   VARIANT    1315   1315       P -> L (in dbSNP:rs357564).
FT                                /FTId=VAR_010983.
FT   VARIANT    1438   1438       E -> D (in BCNS; sporadic NBCCS).
FT                                /FTId=VAR_010984.
FT   CONFLICT   1109   1109       G -> S (in Ref. 2; AAC50496).
FT   CONFLICT   1144   1144       E -> D (in Ref. 2; AAC50496).
FT   CONFLICT   1175   1175       L -> W (in Ref. 2; AAC50496).
FT   CONFLICT   1283   1283       R -> K (in Ref. 2; AAC50496).
FT   CONFLICT   1309   1309       E -> K (in Ref. 2; AAC50496).
FT   CONFLICT   1353   1353       A -> T (in Ref. 2; AAC50496).
SQ   SEQUENCE   1447 AA;  160545 MW;  F2937247BC812F85 CRC64;
     MASAGNAAEP QDRGGGGSGC IGAPGRPAGG GRRRRTGGLR RAAAPDRDYL HRPSYCDAAF
     ALEQISKGKA TGRKAPLWLR AKFQRLLFKL GCYIQKNCGK FLVVGLLIFG AFAVGLKAAN
     LETNVEELWV EVGGRVSREL NYTRQKIGEE AMFNPQLMIQ TPKEEGANVL TTEALLQHLD
     SALQASRVHV YMYNRQWKLE HLCYKSGELI TETGYMDQII EYLYPCLIIT PLDCFWEGAK
     LQSGTAYLLG KPPLRWTNFD PLEFLEELKK INYQVDSWEE MLNKAEVGHG YMDRPCLNPA
     DPDCPATAPN KNSTKPLDMA LVLNGGCHGL SRKYMHWQEE LIVGGTVKNS TGKLVSAHAL
     QTMFQLMTPK QMYEHFKGYE YVSHINWNED KAAAILEAWQ RTYVEVVHQS VAQNSTQKVL
     SFTTTTLDDI LKSFSDVSVI RVASGYLLML AYACLTMLRW DCSKSQGAVG LAGVLLVALS
     VAAGLGLCSL IGISFNAATT QVLPFLALGV GVDDVFLLAH AFSETGQNKR IPFEDRTGEC
     LKRTGASVAL TSISNVTAFF MAALIPIPAL RAFSLQAAVV VVFNFAMVLL IFPAILSMDL
     YRREDRRLDI FCCFTSPCVS RVIQVEPQAY TDTHDNTRYS PPPPYSSHSF AHETQITMQS
     TVQLRTEYDP HTHVYYTTAE PRSEISVQPV TVTQDTLSCQ SPESTSSTRD LLSQFSDSSL
     HCLEPPCTKW TLSSFAEKHY APFLLKPKAK VVVIFLFLGL LGVSLYGTTR VRDGLDLTDI
     VPRETREYDF IAAQFKYFSF YNMYIVTQKA DYPNIQHLLY DLHRSFSNVK YVMLEENKQL
     PKMWLHYFRD WLQGLQDAFD SDWETGKIMP NNYKNGSDDG VLAYKLLVQT GSRDKPIDIS
     QLTKQRLVDA DGIINPSAFY IYLTAWVSND PVAYAASQAN IRPHRPEWVH DKADYMPETR
     LRIPAAEPIE YAQFPFYLNG LRDTSDFVEA IEKVRTICSN YTSLGLSSYP NGYPFLFWEQ
     YIGLRHWLLL FISVVLACTF LVCAVFLLNP WTAGIIVMVL ALMTVELFGM MGLIGIKLSA
     VPVVILIASV GIGVEFTVHV ALAFLTAIGD KNRRAVLALE HMFAPVLDGA VSTLLGVLML
     AGSEFDFIVR YFFAVLAILT ILGVLNGLVL LPVLLSFFGP YPEVSPANGL NRLPTPSPEP
     PPSVVRFAMP PGHTHSGSDS SDSEYSSQTT VSGLSEELRH YEAQQGAGGP AHQVIVEATE
     NPVFAHSTVV HPESRHHPPS NPRQQPHLDS GSLPPGRQGQ QPRRDPPREG LWPPPYRPRR
     DAFEISTEGH SGPSNRARWG PRGARSHNPR NPASTAMGSS VPGYCQPITT VTASASVTVA
     VHPPPVPGPG RNPRGGLCPG YPETDHGLFE DPHVPFHVRC ERRDSKVEVI ELQDVECEER
     PRGSSSN
//
